NMC Founder Shetty Weighs Sale of Pharma Business
(Bloomberg) -- NMC Health Plc founder Bavaguthu Raghuram Shetty is considering selling his Abu Dhabi-based pharmaceuticals business, Neopharma, after drawing interest from potential investors, according to people with knowledge of the matter.
Shetty, who resigned as chairman of the troubled hospital operator last month, has been approached by parties, including regional investors and family offices, the people said, asking not to be identified because the matter is private. Neopharma could be valued at between $700 million and $1 billion, they said.
NMC Founder Shetty Loved Challenges, Until They Ate His Company
The Indian entrepreneur, who left over concerns that he may have misreported the size of his stake in NMC, may sell all or part of Neopharma and use the proceeds to repay loans, the people said. Talks are in preliminary stages and Shetty may decide not to proceed, they said. Neopharma operates in about 50 countries in the Middle East, Africa and Asia.
A spokesman for Shetty's BRS Ventures, which holds 30 companies including NMC and financial services firm Finablr Plc., declined to comment.
Strategic Options
Shetty is working with Houlihan Lokey Inc. to explore strategic options for BRS Ventures after NMC became entangled in allegations of fraud.
Read more: Abu Dhabi Billionaire Considers IPO of Pharmaceuticals Business
Shetty had been considering selling shares in Neopharma before a December report by short seller Carson Block alleged NMC had overpaid for assets, inflated cash balances and understated debt. Since then, the hospital operator has lost two-thirds of its value and five of 11 board members have either been fired or resigned amid a series of financial improprieties.
Related: Italian Investor Is Said to Seek Partner to Bid for NMC
On Monday, NMC asked lenders for a reprieve on its debt and Moody's Investors Service slashed its rating by five levels, saying its financial statements can't be relied on.
To contact the reporter on this story: Nicolas Parasie in Dubai at nparasie1@bloomberg.net
To contact the editors responsible for this story: Stefania Bianchi at sbianchi10@bloomberg.net, Claudia Maedler
©2020 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
